Abstract
Introduction: Youth may be attracted to menthol cigarettes because they are perceived as less harmful and harsh to smoke relative to non-menthol cigarettes. This study examined demographic factors and menthol cigarette smoking patterns as correlates of youth harm perceptions of cigarette smoking and ease of smoking menthol versus non-menthol cigarettes. Methods: Data were from the Wave 1 (2013–2014) youth sample of the Population Assessment of Tobacco and Health Study. Weighted multivariable logistic regression models were used to examine correlations between demographic factors and menthol cigarette smoking patterns (menthol initiation, past 30-day menthol cigarette smoking, and menthol cigarette brand preference), with harm perceptions of cigarette smoking and ease of smoking a menthol cigarette. Results: Nearly half of ever cigarette smoking youth (43%) first used a menthol cigarette; 21% reported past 30-day menthol cigarette smoking; and 42% of past 30-day smokers providing brand information used a menthol cigarette as their preferred brand. In bivariate analyses, initiation with a menthol cigarette and menthol brand preference (versus non-menthol) were correlated with black race, older age at initiation, and past 30-day menthol cigarette smoking. In adjusted models, past 30-day menthol cigarette smoking and menthol cigarette brand preference, but not menthol initiation, were correlated with the perception that menthol cigarettes are easier to smoke. Conclusions: Youth who smoke menthol cigarettes perceive them as easier to smoke, even after adjusting for other factors. Age of initiation and black race emerged as correlates of menthol cigarette initiation, brand preference, and cigarette harm perceptions, and may inform future prevention campaigns.
Original language | English |
---|---|
Pages (from-to) | e107-e116 |
Journal | American Journal of Preventive Medicine |
Volume | 56 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2019 |
Bibliographical note
Publisher Copyright:© 2019 American Journal of Preventive Medicine
Funding
ACV was supported by the Centers of Biomedical Research Excellence P20GM103644 award from the National Institute of General Medical Sciences and National Cancer Institute of NIH under Award Number R03CA212694. AMC was supported by R01DA046359-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or the Food and Drug Administration . ACV was supported by the Centers of Biomedical Research Excellence P20GM103644 award from the National Institute of General Medical Sciences and National Cancer Institute of NIH under Award Number R03CA212694. AMC was supported by R01DA046359-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or the Food and Drug Administration.
Funders | Funder number |
---|---|
National Institute of GeneralMedical Sciences Centers of Biomedical Research Excellence | |
National Institutes of Health (NIH) | R01DA046359-01 |
National Institutes of Health (NIH) | |
National Childhood Cancer Registry – National Cancer Institute | R03CA212694 |
National Childhood Cancer Registry – National Cancer Institute | |
National Institute of General Medical Sciences | P20GM103644 |
National Institute of General Medical Sciences | |
Food and Drug Administration |
ASJC Scopus subject areas
- Epidemiology
- Public Health, Environmental and Occupational Health